Grant opportunity
​Sickle Cell Disease Regional Care Excellence (SoRCE) Program
Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD. Treatment starting in early childhood can prevent or reduce complications such as severe pain episodes, silent strokes, and premature death.
- Funder
- Health Resources and Services Administration / Department of Health and Human Services
- Closes 2026-07-08
- Closes 2026-07-08: Jul 8, 2026
- Award
- up to USD 950,000; floor 0; estimated total USD 6,650,000; 7 expected awards
- Applicant
- Organizations and Institutions
- Discipline
- Health and Biomedical Sciences
- Region
- United States
- Posted
- Jun 5, 2026
Call summary
Overview
Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD. Treatment starting in early childhood can prevent or reduce complications such as severe pain episodes, silent strokes, and premature death. Despite universal identification at birth, fewer than half of children with SCD receive needed treatment. As these children become adolescents and transition to adulthood many are not appropriately identified as candidates for disease-modifying therapies, in part because their doctors are still learning how to use the latest treatments. The program is made up of seven regions with one award recipient per region serving as a Regional Coordinating Hub (RCH). Each award recipient will work with clinical and community-based partners in their region and engage in continuous quality improvement (CQI) initiatives to improve access and quality of care.
Who can apply
Hospitals or clinicsHealth centers.
What it supports
- Health and Biomedical Sciences
- United States
- Official opportunity number: HRSA-26-052.
Funding and duration
- up to USD 950,000; floor 0; estimated total USD 6,650,000; 7 expected awards
Closes 2026-07-08
Closes 2026-07-08: Jul 8, 2026
How to apply
Use the official Grants.gov listing for application package, forms, attachments, and agency-specific instructions. Submit by 2026-07-08 unless the agency updates the official listing.
Call details
Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD. Treatment starting in early childhood can prevent or reduce complications such as severe pain episodes, silent strokes, and premature death. Despite universal identification at birth, fewer than half of children with SCD receive needed treatment. As these children become adolescents and transition to adulthood many are not appropriately identified as candidates for disease-modifying therapies, in part because their doctors are still learning how to use the latest treatments. The program is made up of seven regions with one award recipient per region serving as a Regional Coordinating Hub (RCH). Each award recipient will work with clinical and community-based partners in their region and engage in continuous quality improvement (CQI) initiatives to improve access and quality of care. Eligibility: Hospitals or clinicsHealth centers. Opportunity number: HRSA-26-052. Closing date: 2026-07-08. Funding: up to USD 950,000; floor 0; estimated total USD 6,650,000; 7 expected awards.
Hospitals or clinicsHealth centers.
Health and Biomedical Sciences
United States
Official opportunity number: HRSA-26-052.
up to USD 950,000; floor 0; estimated total USD 6,650,000; 7 expected awards
Closes 2026-07-08: Closes 2026-07-08: Jul 8, 2026.
Confirm the exact deadline time, time zone, and submission route on the official call page.
Plan internal approvals, partner confirmations, budgets, letters, and portal submission before the final deadline.
Use the official Grants.gov listing for application package, forms, attachments, and agency-specific instructions. Submit by 2026-07-08 unless the agency updates the official listing.
Before submitting, check required documents, eligible costs, attachments, page limits, institutional approvals, and whether the opportunity uses an expression of interest, full proposal, registration, or nomination stage.